Journal Home
Search for

Volume 21, Issue 1, Pages 36-42 (January 2010)


View previous. 6 of 14 View next.

Why don’t out-of-treatment individuals enter methadone treatment programmes?

James A. PetersonCorresponding Author Informationemail address, Robert P. Schwartz, Shannon Gwin Mitchell, Heather Schacht Reisinger, Sharon M. Kelly, Kevin E. O’Grady, Barry S. Brown, Michael H. Agar

Received 9 May 2008; received in revised form 16 July 2008; accepted 30 July 2008. published online 22 September 2008.

Abstract 

Background

Despite the proven effectiveness of methadone treatment, the majority of heroin-dependent individuals are out-of-treatment.

Methods

Twenty-six opioid-dependent adults who met the criteria for methadone maintenance who were neither seeking methadone treatment at the time of study enrollment, nor had participated in such treatment during the past 12 months, were recruited from the streets of Baltimore, Maryland through targeted sampling. Ethnographic interviews were conducted to ascertain participants’ attitudes toward methadone treatment and their reasons for not seeking treatment.

Results

Barriers to treatment entry included: waiting lists, lack of money or health insurance, and requirements to possess a photo identification card. For some participants, beliefs about methadone such as real or rumored side effects, fear of withdrawal from methadone during an incarceration, or disinterest in adhering to the structure of treatment programmes kept them from applying. In addition, other participants were not willing to commit to indefinite “maintenance” but would have accepted shorter time-limited methadone treatment.

Conclusion

Barriers to treatment entry could be overcome by an infusion of public financial support to expand treatment access, which would reduce or eliminate waiting lists, waive treatment-related fees, and/or provide health insurance coverage for treatment. Treatment programmes could overcome some of the barriers by waiving their photo I.D. requirements, permitting time-limited treatment with the option to extend such treatment upon request, and working with corrections agencies to ensure continued methadone treatment upon incarceration.

Friends Research Institute Inc., Social Research Center, 1040 Park Avenue, Suite 103, Baltimore, MD 21201, USA

Corresponding Author InformationCorresponding author. Tel.: +1 410 837 3977x228; fax: +1 410 752 4218.

PII: S0955-3959(08)00169-2

doi:10.1016/j.drugpo.2008.07.004


View previous. 6 of 14 View next.